{"organizations": [], "uuid": "763b1abcf923bfafa9348a01b3df0c6a48061ce7", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180215.html", "section_title": "Archive News &amp; Video for Thursday, 15 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-celularity-announces-formation-of/brief-celularity-announces-formation-of-co-with-250-mln-in-funding-from-celgene-united-therapeutics-others-idUSFWN1Q51E2", "country": "US", "domain_rank": 408, "title": "BRIEF-Celularity Announces Formation Of Co With $250 Mln In Funding From Celgene, United Therapeutics, Others", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.046, "site_type": "news", "published": "2018-02-16T01:13:00.000+02:00", "replies_count": 0, "uuid": "763b1abcf923bfafa9348a01b3df0c6a48061ce7"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-celularity-announces-formation-of/brief-celularity-announces-formation-of-co-with-250-mln-in-funding-from-celgene-united-therapeutics-others-idUSFWN1Q51E2", "ord_in_thread": 0, "title": "BRIEF-Celularity Announces Formation Of Co With $250 Mln In Funding From Celgene, United Therapeutics, Others", "locations": [], "entities": {"persons": [{"name": "sorrento", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-celularity announces formation of co", "sentiment": "negative"}, {"name": "united therapeutics", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 15 (Reuters) - Celularity:\n* ‍CELULARITY ANNOUNCES $250 MILLION IN FUNDING TO DELIVER TREATMENTS FOR CANCER, INFLAMMATORY AND DEGENERATIVE DISEASES, AND FUNCTIONAL REGENERATION​\n* CELULARITY SAYS IS ANNOUNCING FORMATION OF CO WITH $250 MILLION IN FUNDING WITH CONTRIBUTIONS FROM CELGENE, UNITED THERAPEUTICS, SORRENTO THERAPEUTICS Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-16T01:13:00.000+02:00", "crawled": "2018-02-16T17:08:05.098+02:00", "highlightTitle": ""}